Alfresa HoldingsALFRY 75 Days Payable is 127.28 as of Mar. 2026, which is 10% above its 10-year median of 115.78. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.31 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 115 Medical Distribution companies, Alfresa Holdings ranks better than 75.65% on this metric.
The historical rank and industry rank for Alfresa Holdings's Days Payable or its related term are showing as below:
ALFRY'
s Days Payable Range Over the Past 10 Years
Min: 108.57 Med: 115.78 Max: 122.11
Current: 114.3
During the past 13 years, Alfresa Holdings's highest Days Payable was 122.11. The lowest was 108.57. And the median was 115.78.
ALFRY's Days Payable is ranked better than 75.65% of 115
companies
in the Medical Distribution industry
Industry Median: 79.81
vs ALFRY: 114.30
Alfresa Holdings's Days Payable
increased
from Mar. 2025 (126.27) to Mar. 2026 (127.28).
It may suggest that Alfresa Holdingsdelayed paying its suppliers.
Alfresa Holdings Days Payable Related Terms
Alfresa Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Alfresa Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Alfresa Holdings's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (ALFRY) has a Days Payable of 127.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alfresa Holdings and its competitors. This is 10% above median its historical median of 115.78. Over the past decade, Alfresa Holdings' Days Payable has ranged from 108.57 to 122.11. According to the industry distribution chart, Alfresa Holdings ranks #28 out of 115 companies in the Medical Distribution industry, placing it in the top 24.3%.
Is Alfresa Holdings' Days Payable too high?
Alfresa Holdings' current Days Payable of 127.28 is 10% above median its 10-year median of 115.78. Over the past 10 years, this metric has ranged from a low of 108.57 to a high of 122.11. The Medical Distribution industry median Days Payable is 79.81. Alfresa Holdings' value of 127.28 is 59.5% above this industry median. Based on the distribution chart, Alfresa Holdings ranks #28 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #28 out of 115 companies for Days Payable. This places Alfresa Holdings in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 79.81. Alfresa Holdings' value of 127.28 is 59.5% above this benchmark. Historically, Alfresa Holdings' own Days Payable has ranged from 108.57 to 122.11 over the past decade. While the company's 10-year median is 115.78 vs. the industry median of 79.81, Alfresa Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.81, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Days Payable of 127.28 is 59.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Days Payable is 79.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Days Payable is 127.28, which is 10% above median its own 10-year median of 115.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.31, compared to a current price of $13.80 — trading 15.4% below its estimated fair value. The current Days Payable is 127.28, which is 10% above median its 10-year median of 115.78 and 59.5% above the Medical Distribution industry median of 79.81. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current Days Payable is 127.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.80 is trading 15.4% below its estimated GF Value™ of $16.31.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
Days Payable: 127.28 (10% above median its 10-year median of 115.78)
GF Value™: $16.31 vs. price of $13.80 (15.4% below fair value)
Industry Position: 59.5% above the Medical Distribution median (#28 of 115)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score
Get the complete analysis for ALFRY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
